Martin Shkreli

Page 4 of 8

Mylan NV Chief Executive Officer Heather Bresch Interview
Finance

Mylan CEO Blamed Obamacare for EpiPen Sticker Shock

By
August 24, 2016
Democratic Presidential Nominee Hillary Clinton Delivers Speech On The Economy
Health

Pharma Bro Martin Shkreli Takes On Hillary Clinton Over Mylan’s EpiPen

By
August 24, 2016
Annual Allen And Co. Investors Meeting Draws CEO's And Business Leaders To Sun Valley, Idaho
Tech

A Definitive List of Recently ‘Hacked’ CEOs and Celebrities

By
July 27, 2016
House Oversight Hearing On Prescription Drug Price Increases
Leadership

The ‘Most Hated Man on the Internet’ Hates Brunch

By Maxine Builder and Extra Crispy
July 25, 2016
Former KaloBios Pharmaceuticals Chief Executive Officer Martin Shkreli Court Appearance
Tech

Martin Shkreli is Getting Into Magic: the Gathering, and Gamers Are Conflicted

By
July 10, 2016
Martin Shkreli’s Former Company, Back in Business, Vows No Crazy Drug Prices
Health

Martin Shkreli’s Former Company, Back in Business, Vows No Crazy Drug Prices

By
July 1, 2016
Former Pharmaceutical CEO Martin Shkreli Appears In Court Over Multiple Fraud Charges
Leadership

Here’s What ‘The Most Hated Man in America’ Thinks About Donald Trump

By
June 3, 2016
Coins2Day Global Forum 2015
Leadership

Meet Health Care’s Major Spoilers: Theranos, Valeant, and Turing Pharmaceuticals

By
May 10, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Finance

Biotech Stocks Are Down 25% So Far This Year

By
May 6, 2016
Former Pharmaceutical CEO Martin Shkreli Appears In Court Over Multiple Fraud Charges
Finance

Martin Shkreli Could Be Facing Even More Charges

By
May 3, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Valeant’s CEO Will Have to Testify at a U.S. Congressional Hearing

By
March 28, 2016
House Oversight Hearing On Prescription Drug Price Increases
Health

Martin Shkreli’s Former Colleague: We Advised Him Against That Infamous Price Hike

By
March 17, 2016
MSMB Capital Management CIO Martin Shkreli
Finance

Even Pharma Bro Martin Shkreli Wouldn’t Touch Valeant

By
March 15, 2016
Hillary Clinton Holds Post-Super Tuesday Rally In NYC
Finance

This Is Why Hillary Clinton’s Attack on Drug Price Hikes Doesn’t Add Up

By
March 4, 2016
UNITED STATES - FEBRUARY 04: Martin Shkreli, former CEO Turing Pharmaceuticals, invoked his Fifth Amendment right against self-incrimination during a House Oversight and Government Reform Committee in Rayburn Building on "methods and reasoning behind recent drug price increases," February 04, 2016. Turing had raised the price of Daraprim, used by AIDS and cancer patients, from $13.50 to $750 a pill. (Photo By Tom Williams/CQ Roll Call)
Leadership

Several Witnesses in the Martin Shkreli Case Are Worried About Retaliation

By
February 19, 2016

Most Popular